Position in ALNY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,548,029
+$120,377 QoQ
Shares Held
7,701
+26.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.09089728606674458.ToString("F0")%
Shared 0.ToString("F0")%
None 99.90910271393325.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $112,535,820 across 48 Biotechnology names. ALNY ranks #4 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
114,449 | $51,106,055 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,108 | $30,989,044 | |
| 3 | ARGX |
Argenx SE
|
3,878 | $2,831,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,701 | $2,548,029 | |
| 5 | INSM |
INSMED Inc
|
15,416 | $2,520,822 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,207 | $1,929,631 | |
| 7 | EXEL |
Exelixis, Inc.
|
32,818 | $1,407,563 | |
| 8 | RPRX |
Royalty Pharma plc
|
29,108 | $1,396,310 |
All Filings in ALNY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,548,029 | 7,701 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $2,427,652 | 6,105 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $2,948,496 | 6,466 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,306,642 | 4,007 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $978,552 | 3,624 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,034,892 | 4,398 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $511,280 | 1,859 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $419,904 | 1,728 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $351,356 | 2,351 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $474,312 | 2,478 | Shares | Defined | 2024-02-02 | |
| 2023-03-31 | $266,023 | 1,328 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $348,869 | 1,468 | Shares | Defined | 2023-02-17 | |
| 2022-06-30 | $729,249 | 5,000 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $1,130,619 | 6,924 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $1,287,959 | 7,595 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,246,712 | 6,603 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $1,112,559 | 6,563 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $808,312 | 5,725 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $227,835 | 1,753 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $200,781 | 1,379 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $262,006 | 1,769 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $210,840 | 1,937 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||